BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33914050)

  • 41. Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study.
    Grimes DR
    BMJ Open; 2024 Feb; 14(2):e078551. PubMed ID: 38309749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical cancer screening in Jordan; a review of the past and an outlook to the future - facts and figures.
    Fram R; Fram KM; Saleh S; Muhidat N; Fram F; Khouri Z; Tarawneh B; Tarawneh N
    Prz Menopauzalny; 2023 Mar; 22(1):24-29. PubMed ID: 37206675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reallocating Cervical Cancer Preventive Service Spending from Low- to High-Value Clinical Scenarios.
    Rockwell MS; Armbruster SD; Capucao JC; Russell KB; Rockwell JA; Perkins KE; Huffstetler AN; Mafi JN; Fendrick AM
    Cancer Prev Res (Phila); 2023 Jul; 16(7):385-391. PubMed ID: 36976753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions.
    Burger EA; de Kok IMCM; O'Mahony JF; Rebolj M; Jansen EEL; de Bondt DD; Killen J; Hanley SJ; Castanon A; Regan MC; Kim JJ; Canfell K; Smith MA
    Elife; 2022 Oct; 11():. PubMed ID: 36222673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptions.
    Burger EA; de Kok IMCM; O'Mahony JF; Rebolj M; Jansen EEL; de Bondt DD; Killen J; Hanley SJ; Castanon A; Kim JJ; Canfell K; Smith MA; Regan MC
    medRxiv; 2022 Jul; ():. PubMed ID: 35923317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study.
    Maeda M; Hisa T; Matsuzaki S; Lee M; Mabuchi S; Kamiura S
    Curr Oncol; 2022 May; 29(5):3770-3779. PubMed ID: 35621692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.
    Aninye IO; Berry-Lawhorn JM; Blumenthal P; Felder T; Jay N; Merrill J; Messman JB; Nielsen S; Perkins R; Rowen T; Saslow D; Trimble CL; Smith-McCune K
    J Womens Health (Larchmt); 2021 Dec; 30(12):1667-1672. PubMed ID: 34871035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.
    Wright JD; Chen L; Tergas AI; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL
    JAMA Netw Open; 2021 Apr; 4(4):e218373. PubMed ID: 33914050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
    Qin J; Shahangian S; Saraiya M; Holt H; Gagnon M; Sawaya GF
    Gynecol Oncol; 2021 Nov; 163(2):378-384. PubMed ID: 34507826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of cervical cancer screening among Medicaid beneficiaries.
    Dillon J; Chen L; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Wright JD
    BJOG; 2022 Jun; 129(7):1104-1111. PubMed ID: 34882962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.